Questions? Feedback? powered by Olark live chat software
Permits and Restrictions

View Permits View Restrictions

Organism Homo sapiens, human
Components HCC1599, ATCC CRL-2331 HCC1937, ATCC CRL-2336 HCC1143, ATCC CRL-2321 MDA-MB-468, ATCC HTB-132 HCC38, ATCC CRL-2314 HCC70, ATCC CRL-2315 HCC1806, ATCC CRL-2335 HCC1187, ATCC CRL-2322 DU4475, ATCC HTB-123
Applications Biological understanding of top genetic alterations across tumor types Validation and characterization of potential cancer driver genes Functional profiling and molecular profiling of subtype-specific cancer cell lines Testing small molecules or biologics for cancer drug development
Type Strain no
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments A panel of 9 triple-negative breast tumor cell lines sharing a basal-like morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information. RefLehmann BD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121: 2750-2767, 2011. PubMed: 21633166
Product Format frozen
Storage Conditions LN vapor (less than -130°C) only
Permits

These permits may be required for shipping this product to Australia:

  • License agreement required for commercial customer uses.
  • DAFF Import Permit formerly known as AQIS Import Permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment.
Basic Documentation Product Sheet Certificate of Analysis SDS
Other Documentation Cancer cell line mutation data
Restrictions

Unless the Purchaser has a separate license agreement with The University of Texas M. D. Anderson Cancer Center (“Institution”), the ATCC Material is subject to the following restrictions:

  1. The ATCC Material (and any Modifications, Unmodified Derivatives and/or Progeny thereof) may not be used (1) for commercial purposes or Commercial Use by any Purchaser, or (2) by for-profit or commercial entities for any purpose, provided, however, that ATCC Material that is purchased from ATCC as deoxyribonucleic acid and/or ribonucleic acid or nucleotide chains of any length (hereinafter, “Nucleic Acids”) may be used for internal research purposes by any Purchaser of Nucleic Acids;
  2. Purchaser may not transfer ATCC Materials, Modifications, Unmodified Derivatives, or Progeny to any for-profit entity or commercial entity; and
  3. Purchaser may not use ATCC Materials (or any Modifications, Unmodified Derivatives and/or Progeny thereof) in connection with any research, collaboration or other activities involving a third party that is a commercial entity or for-profit entity.

The restrictions set forth above are in addition to the restrictions set forth in the ATCC Material Transfer Agreement. Capitalized terms have the meanings set forth in the ATCC Material Transfer Agreement unless otherwise indicated above.

For instructions on how to obtain a license from Institution, please contact Dustin J. Romine, M.A. at the Institution Office of Technology Commercialization via email at dromine@mdanderson.org.

Purchaser acknowledges and agrees that ATCC will send Purchaser’s contact information and order details to Institution’s Office of Technology Commercialization.

E: care@invitro.com.au
P: 1300 552 003